Clinical Trial Update: Investigator-Sponsored Protocol - Continued Use of Ibalizumab [Phase 2]

View source ↗

Summary

This investigator-sponsored Phase 2 trial update covers the continued use of ibalizumab for HIV infection and indicates the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ibalizumab (ibalizumab)

Snippet

Sponsor: Kaiser Permanente | Conditions: HIV Infections | Phase 2 | Status: COMPLETED